|4Jun 25, 7:05 PM ET

WAN MARK A 4

4 · ACELRX PHARMACEUTICALS INC · Filed Jun 25, 2019

Insider Transaction Report

Form 4
Period: 2019-06-25
WAN MARK A
Director
Transactions
  • Award

    Common Stock

    2019-06-25+3,7503,750 total
  • Award

    Stock Option (Right to Buy)

    2019-06-25+7,5007,500 total
    Exercise: $2.19From: 2019-07-25Exp: 2029-06-25Common Stock (7,500 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The restricted stock units shall vest in two equal consecutive annual installments on June 25, 2020 and June 25, 2021, subject to Reporting Person's continuous service to the Company.
  • [F3]The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Reporting Person's continuous service to the Company.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION